Literature DB >> 35858244

Dietary fat composition shapes bile acid metabolism and severity of liver injury in a pig model of pediatric NAFLD.

Rodrigo Manjarín1, Kayla Dillard2, Morgan Coffin1, Gabriella V Hernandez1, Victoria A Smith1, Trista Noland-Lidell1, Tanvi R Gehani3, Hayden J Smart1, Kevin Wheeler4, Kimberly A Sprayberry1, Mark S Edwards1, Rob K Fanter5,6, Hunter Glanz7, Chad Immoos8, Tasha M Santiago-Rodriguez9, Jason M Blank4, Douglas G Burrin10, Brian D Piccolo11,12, Mohammed Abo-Ismail1, Michael R La Frano2,13, Magdalena Maj4,14.   

Abstract

The objective of this study was to investigate the effect of dietary fatty acid (FA) composition on bile acid (BA) metabolism in a pig model of NAFLD, by using a multiomics approach combined with histology and serum biochemistry. Thirty 20-day-old Iberian pigs pair-housed in pens were randomly assigned to receive 1 of 3 hypercaloric diets for 10 wk: 1) lard-enriched (LAR; n = 5 pens), 2) olive oil-enriched (OLI; n = 5), and 3) coconut oil-enriched (COC; n = 5). Animals were euthanized on week 10 after blood sampling, and liver, colon, and distal ileum (DI) were collected for histology, metabolomics, and transcriptomics. Data were analyzed by multivariate and univariate statistics. Compared with OLI and LAR, COC increased primary and secondary BAs in liver, plasma, and colon. In addition, both COC and OLI reduced circulating fibroblast growth factor 19, increased hepatic necrosis, composite lesion score, and liver enzymes in serum, and upregulated genes involved in hepatocyte proliferation and DNA repair. The severity of liver disease in COC and OLI pigs was associated with increased levels of phosphatidylcholines, medium-chain triacylglycerides, trimethylamine-N-oxide, and long-chain acylcarnitines in the liver, and the expression of profibrotic markers in DI, but not with changes in the composition or size of BA pool. In conclusion, our results indicate a role of dietary FAs in the regulation of BA metabolism and progression of NAFLD. Interventions that aim to modify the composition of dietary FAs, rather than to regulate BA metabolism or signaling, may be more effective in the treatment of NAFLD.NEW & NOTEWORTHY Bile acid homeostasis and signaling is disrupted in NAFLD and may play a central role in the development of the disease. However, there are no studies addressing the impact of diet on bile acid metabolism in patients with NAFLD. In juvenile Iberian pigs, we show that fatty acid composition in high-fat high-fructose diets affects BA levels in liver, plasma, and colon but these changes were not associated with the severity of the disease.

Entities:  

Keywords:  Iberian pig; NASH; lipidomics; pediatric model; transcriptomics

Mesh:

Substances:

Year:  2022        PMID: 35858244      PMCID: PMC9423774          DOI: 10.1152/ajpendo.00052.2022

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   5.900


  80 in total

1.  Missing value estimation methods for DNA microarrays.

Authors:  O Troyanskaya; M Cantor; G Sherlock; P Brown; T Hastie; R Tibshirani; D Botstein; R B Altman
Journal:  Bioinformatics       Date:  2001-06       Impact factor: 6.937

2.  Lowering of serum lipid concentrations: mechanisms used by unsaturated fats, nicotinic acid, and neomycin: excretion of sterols and bile acids.

Authors:  G A GOLDSMITH; J G HAMILTON; O N MILLER
Journal:  Arch Intern Med       Date:  1960

3.  Dietary habits and nutrient intake in non-alcoholic steatohepatitis.

Authors:  Kumiko Toshimitsu; Bunzo Matsuura; Ikuko Ohkubo; Tetsuji Niiya; Shinya Furukawa; Yoichi Hiasa; Mieko Kawamura; Kiyoshi Ebihara; Morikazu Onji
Journal:  Nutrition       Date:  2006-11-29       Impact factor: 4.008

4.  Mice fed a lipogenic methionine-choline-deficient diet develop hypermetabolism coincident with hepatic suppression of SCD-1.

Authors:  Gizem Rizki; Lorenzo Arnaboldi; Bianca Gabrielli; Jim Yan; Gene S Lee; Ray K Ng; Scott M Turner; Thomas M Badger; Robert E Pitas; Jacquelyn J Maher
Journal:  J Lipid Res       Date:  2006-07-08       Impact factor: 5.922

5.  Dietary determinants of hepatic steatosis and visceral adiposity in overweight and obese youth at risk of type 2 diabetes.

Authors:  Rebecca C Mollard; Martin Sénéchal; Andrea C MacIntosh; Jacqueline Hay; Brandy A Wicklow; Kristy D M Wittmeier; Elizabeth A C Sellers; Heather J Dean; Lawrence Ryner; Lori Berard; Jonathan M McGavock
Journal:  Am J Clin Nutr       Date:  2014-02-12       Impact factor: 7.045

6.  Gut bacterial phospholipase Ds support disease-associated metabolism by generating choline.

Authors:  Carina L Chittim; Ana Martínez Del Campo; Emily P Balskus
Journal:  Nat Microbiol       Date:  2018-11-19       Impact factor: 17.745

7.  Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease.

Authors:  Jeffrey B Schwimmer; Reena Deutsch; Jeffrey B Rauch; Cynthia Behling; Robert Newbury; Joel E Lavine
Journal:  J Pediatr       Date:  2003-10       Impact factor: 4.406

8.  Are saturated fatty acids and insulin resistance associated with fatty liver in obese children?

Authors:  Dimitrios Papandreou; Israel Rousso; Pavlos Malindretos; Areti Makedou; Tatiana Moudiou; Ifigenia Pidonia; Athina Pantoleon; Ipolliti Economou; Ioannis Mavromichalis
Journal:  Clin Nutr       Date:  2008-01-30       Impact factor: 7.324

9.  Beneficial effects versus toxicity of medium-chain triacylglycerols in rats with NASH.

Authors:  Charles S Lieber; Leonore M DeCarli; Maria A Leo; Ki M Mak; Anatoly Ponomarenko; Chaoling Ren; Xiaolei Wang
Journal:  J Hepatol       Date:  2007-12-10       Impact factor: 25.083

Review 10.  Influence of dietary macronutrients on liver fat accumulation and metabolism.

Authors:  Siôn A Parry; Leanne Hodson
Journal:  J Investig Med       Date:  2017-09-24       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.